Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)
|
August 31, 2001
Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?
R T Reilly, L A Emens, E M Jaffee
Endocrine-Related Cancer
|
March 25, 2005
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity
L A Emens, R T Reilly, E M Jaffee
Immunology Today
|
March 11, 2000
How much longer will tumour cells fool the immune system?
S Ferrone, J F Finerty, E M Jaffee, et al.
Advances in Immunology
|
December 22, 1999
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance
F M Marincola, E M Jaffee, D J Hicklin, et al.
Human Gene Therapy
|
May 15, 1998
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine
M C Thomas, T F Greten, D M Pardoll, et al.
Current Opinion in Molecular Therapeutics
|
March 16, 2001
Chemotherapy: friend or foe to cancer vaccines?
L A Emens, J P Machiels, R T Reilly, et al.
The Journal of Experimental Medicine
|
November 1, 1995
A reassessment of the role of B7-1 expression in tumor rejection
T C Wu, A Y Huang, E M Jaffee, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
November 1, 1992
Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines
P T Golumbek, F M Hamzeh, E M Jaffee, et al.
Analytical Biochemistry
|
March 20, 1995
Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry
A S Woods, A Y Huang, R J Cotter, et al.
Cancer Research
|
December 15, 1993
Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design
P T Golumbek, R Azhari, E M Jaffee, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Current Opinion in Investigational Drugs (London, England : 2000)
|
August 31, 2001
Humoral and cellular immune responses: independent forces or collaborators in the fight against cancer?
R T Reilly, L A Emens, E M Jaffee
Endocrine-Related Cancer
|
March 25, 2005
Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity
L A Emens, R T Reilly, E M Jaffee
Immunology Today
|
March 11, 2000
How much longer will tumour cells fool the immune system?
S Ferrone, J F Finerty, E M Jaffee, et al.
Advances in Immunology
|
December 22, 1999
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance
F M Marincola, E M Jaffee, D J Hicklin, et al.
Human Gene Therapy
|
May 15, 1998
Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine
M C Thomas, T F Greten, D M Pardoll, et al.
Current Opinion in Molecular Therapeutics
|
March 16, 2001
Chemotherapy: friend or foe to cancer vaccines?
L A Emens, J P Machiels, R T Reilly, et al.
The Journal of Experimental Medicine
|
November 1, 1995
A reassessment of the role of B7-1 expression in tumor rejection
T C Wu, A Y Huang, E M Jaffee, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
November 1, 1992
Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines
P T Golumbek, F M Hamzeh, E M Jaffee, et al.
Analytical Biochemistry
|
March 20, 1995
Simplified high-sensitivity sequencing of a major histocompatibility complex class I-associated immunoreactive peptide using matrix-assisted laser desorption/ionization mass spectrometry
A S Woods, A Y Huang, R J Cotter, et al.
Cancer Research
|
December 15, 1993
Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design
P T Golumbek, R Azhari, E M Jaffee, et al.
Page
of 5